Guidelines

Canadian guidance now available for Abbott Panbio COVID-19 Antigen Rapid Test
Healthcare professionals and nonhealthcare personnel using Panbio as a point-of-care test must be aware of its limitations and uncertainties.
Key clinical guidelines and statements – September to October, 2020
Links to Canadian clinical guidelines and statements available online free-of-charge, recently updated with resources on COVID-19, COVID-19 vaccine, Ebola virus vaccine, influenza vaccine, pain after surgery and type 2 diabetes management.

Canadian atrial fibrillation guidelines completely updated for 2020

Designed to help improve clinical management of an important and challenging arrhythmia.
Key clinical guidelines and statements – June to August, 2020

Most recent updates include resources on cannabis in adolescents, corticosteroids for bronchopulmonary dysplasia in preterm infants, COVID-19, dementia, diabetes-low carbohydrate diets, influenza 2020/21, naloxone, obesity, pulmonary arterial hypertension, syncope, ventricular tachycardia/fibrillation.
New Canadian consensus guidelines for pharmacist prescribing of naloxone

All patients receiving an opioid should be provided with take-home naloxone and counselled by a pharmacist
New Canadian statement on management of pulmonary hypertension

Joint Canadian Cardiovascular Society–Canadian Thoracic Society statement outlines current approach to diagnosis and management of pulmonary hypertension
First Canadian guidance document on management of syncope

Canadian Cardiovascular Society issues first clinical practice guideline on assessment and management of syncope
2020/2021 Canadian influenza guidelines now available

Annual update provides comprehensive information on influenza, recommended vaccine recipients, available vaccines and choice of vaccine
2020 Canadian hypertension guidelines now available, with separate guidelines for managing resistant cases

Provide expert guidance on the prevention, diagnosis, risk assessment and treatment of hypertension in adults and children
Canadian interim guidelines for managing patients with moderate to severe COVID-19

Provide advice on timely, effective and safe supportive management of adults and children with suspected or confirmed COVID-19

Canadian guidance now available for Abbott Panbio COVID-19 Antigen Rapid Test

Key clinical guidelines and statements – September to October, 2020

Canadian atrial fibrillation guidelines completely updated for 2020

Key clinical guidelines and statements – June to August, 2020

New Canadian consensus guidelines for pharmacist prescribing of naloxone

New Canadian statement on management of pulmonary hypertension

First Canadian guidance document on management of syncope

2020/2021 Canadian influenza guidelines now available

2020 Canadian hypertension guidelines now available, with separate guidelines for managing resistant cases

Canadian interim guidelines for managing patients with moderate to severe COVID-19

>> Click here for key clinical guidelines and statements